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Objective: To investigate the predictors of persistence or resolution of preoperative urgency urinary
incontinence (UUI) in women following transvaginal mesh (TVM) repair for advanced pelvic organ
prolapse (POP).
Material and methods: Patients with advanced POP undergoing TVM repair between 2008 and 2013 in a
tertiary hospital were recruited. All patients underwent evaluation including a structured urogyneco-
logical questionnaire, voiding diary, pelvic examination using the POP-quantitation system, and urody-
namic testing before and after surgery, and intraoperative cystoscopy. Patient demographics, lower
urinary tract symptoms, urodynamic ﬁndings, and severity of prolapse were analyzed between women
with and without preoperative UUI.
Results: Of 174 patients who underwent TVM repair, 49 (28.2%) had preoperative UUI; after operation, 23
(13.2%) were found to have postoperative UUI and 13 (7.5%) developed de novo UUI. For those 49 patients
with preoperative UUI, 10 (20.4%) had persistent UUI and 19 (38.8%) developed de novo stress urinary
incontinence postoperatively. The prevalence of preoperative bladder outlet obstruction, preoperative
maximal cystometric capacity (MCC) < 300 mL, preoperative severe bladder trabeculation, and duration
of POP symptoms > 60 months were signiﬁcantly higher in patients with persistent UUI than without it.
Logistic regression demonstrated that preoperative MCC< 300 mL, severe bladder trabeculation, and
duration of POP symptoms > 60 months were associated with persistent UUI after prolapse repair.
Conclusion: For womenwith identiﬁed preoperative risk factors, including MCC< 300 mL, severe bladder
trabeculation, and POP symptoms > 60 months, preoperative counseling should consist of a discussion
about persistent UUI symptoms following TVM repair and the development of de novo stress urinary
incontinence.
Copyright © 2015, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All
rights reserved.Introduction
Pelvic organ prolapse (POP) is a common condition that can
impair a woman's quality of life. Because of distortion in the lower
urinary tract, severe POP causes signs of bladder outlet obstruction
(BOO) [1], detrusor overactivity (DO) [2], bladder trabeculation [3],
reduced maximum urine ﬂow rates, and elevated postvoid residual
volumes [4]. Women with POP present with a variety of lower
urinary tract symptoms (LUTS), such as overactive bladderand Gynecology, Chang Gung
n Street, Kweishan, Taoyuan,
g).
bstetrics & Gynecology. Publishedsyndrome (OAB), urinary incontinence, and voiding difﬁculty [5].
According to an International Continence Society (ICS) and Inter-
national Urogynecological Association joint report, OAB is deﬁned
as urinary urgency, usually accompanied by frequency and noctu-
ria, with or without urgency urinary incontinence (UUI) [6]. OAB,
especially OAB with UUI affects health-related quality of life and
interferes with daily activities [7]. The overall prevalence of OAB is
similar in men and women, but OAB with UUI occurs more often in
women [8]. Thus, both POP and OAB are commonly encountered
together in women. Several authors have reported that vaginal
surgery for POP signiﬁcantly reduced OAB in elderly women [9,10];
however, which factors determine the persistence or disappearance
of UUI in women with POP after surgery still remains unclear. This
study was conducted to investigate the predictors of persistence orby Elsevier Taiwan LLC. All rights reserved.
Table 1
Characteristics of women with pelvic organ prolapse (POP) with and without pre-
operative urgency urinary incontinence (UUI).
UUI (n ¼ 49) No UUI (n ¼ 125) p
Age (y) 67.8 ± 10.3 63.9 ± 10.0 0.024
BMI (kg/m2) 25.9 ± 4.5 25.1 ± 2.7 0.921
Parity 4.5 ± 1.4 4.3 ± 1.5 0.217
Duration of POP (mo) 40.1 ± 32.9 37.6 ± 28.1 0.672
DM 6 (12.2) 17 (13.6) 0.812
Duration of POP > 60 mo 19 (38.8) 33 (26.4) 0.109
ICS Stage 4 22 (44.9) 52 (41.6) 0.692
Preop voiding difﬁculty 25 (51) 55 (44) 0.403
Protruding vaginal mass 44 (90) 118 (94.4) 0.927
Bearing down sensation 42 (85.7) 106 (84.8) 0.514
Severe preop trabeculation 24 (49) 52 (41.6) 0.377
Preop BOO 7 (14.3) 15 (12) 0.683
Preop MCC < 300 mL 16 (12.8) 16 (32.7) 0.002
Preop RU > 100 mL 16 (32.7) 33 (26.4) 0.409
Preop DO 8 (16.3) 7 (5.6) 0.032
Data are presented as mean ± standard deviation or n (%).
BMI¼ body mass index; BOO ¼ bladder outlet obstruction; DM¼ diabetes mellitus;
DO¼ detrusor overactivity; ICS¼ International Continence Society; MCC¼maximal
cystometric capacity; Preop ¼ preoperative; RU ¼ residual urine.
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(TVM) repair of advanced POP.
Materials and methods
FromNovember 2008 to January 2013, consecutive patientswith
advanced POP who underwent TVM repair but without concomi-
tant anti-incontinence surgery in a tertiary hospital were recruited.
We reviewed the patient's characteristics and outcome retrospec-
tively in January 2014 (at least 12 months after surgery). Inclusion
criteria includedwomenwho received TVM repair due to Stage 3 or
4 prolapse as deﬁned by the ICS POP-Quantiﬁcation (POP-Q) system
[11]. Patients who had preoperative stress urinary incontinence
(SUI), had undergone anti-incontinence surgery, did not undergo
urodynamic and cystoscopic testing, and patients without the
ability to complete the questionnaire were excluded. The present
studywas approved by the Ethics Committee of the hospital (Chang
Gung Memorial Hospital in Taiwan) (No. 103-0813B).
The preoperative evaluation of patients with severe POP in this
retrospective cohort study included general and obstetric histories,
a voiding diary, 1-hour pad test, pelvic examination applying the
POP-Q system, and multichannel urodynamic testing and a pessary
test [12]. Patients were interviewed by answering a structured
urogynecologic questionnaire regarding the presence of LUTS, as
described by Liang et al [13], in which LUTS was deﬁned based on
the ICS deﬁnitions [14]. In addition to the items on LUTS, we asked
the patients if they experienced any POP symptoms including a
protruding vaginal mass and bearing down sensation. A single
investigator performed diagnostic cystoscopy to evaluate the
bladder for the presence and severity of trabeculation during sur-
gery using the grading system of Liang et al [3]. The patients were
divided into two trabeculation groups: Group 1 included Grades 3
and 4 with severe bladder trabeculation, and Group 2 included
Grades 0e2 with no to moderate trabeculation.
The TVM procedures included the use of the Perigee/Apogee
(AMS, Inc., Minnetonka, MN, USA), and Prolift systems (Ethicon,
Piscataway, NJ, USA). Anterior vaginal wall mesh used Perigee or
anterior Prolift; posterior vaginal wall mesh referred to Apogee or
posterior Prolift. Anterior vaginal wall mesh was performed for the
anterior compartment prolapse; anterior and posterior vaginal wall
mesh procedures were done for the treatment of anterior, posterior,
and apical compartments prolapse. Additional surgical procedures
for prolapse repair included vaginal hysterectomy and posterior
colporrhaphy.
Postoperative follow-up examinations were done at 1 month, 6
months, and 1 year after surgery, and annually thereafter. At the 6-
month follow-up, postoperative urodynamic studies were per-
formed on all patients. The same questionnaires and pelvic exam-
inations were done at 6 months and 12 months after surgery.
UUI was the complaint of involuntary urine leakage accompa-
nied by or immediately preceded by urgency [14]. A diagnosis of
persistent UUI was made if the patient had UUI following TVM
repair. SUI was the complaint of involuntary urine leakage on effort
or exertion, or on sneezing or coughing [14]. DO was diagnosed
when a patient had involuntary detrusor contractions during ﬁlling
cystometry that did or did not lead to urinary leakage [14]. BOOwas
deﬁned as a maximum ﬂow rate of < 12 mL/s by the instrumented
uroﬂometry (voided volume in excess of 100mL), with the detrusor
pressure at a maximum ﬂow > 20 cm of water [9]. The terminology
used in this article conforms to the recommendations of the ICS and
International Urogynecological Association, unless otherwise
stated [14].
Parameters were compared between patients with and without
preoperative UUI, including LUTS, urodynamic variables, cysto-
scopic bladder trabeculation, POP symptoms, and severity of POP.Analyses were performed using the unpaired two-tailed Student t
test for normally distributed continuous data, the ManneWhitney
U test for continuous data that did not ﬁt a Gaussian curve, and
Fisher's exact test for categorical data. The urodynamic data were
compared using paired t tests. Multivariable logistic regressionwas
done to determine independent predictors of persistent UUI after
TVM repair; the involved parameters encompassed age, parity,
body mass index, duration of POP, diabetes mellitus, ICS Stage 4,
preoperative voiding difﬁculty, preoperative protruding vaginal
mass and bearing down sensation, trabeculation, preoperative
BOO, preoperative MCC< 300 mL, preoperative RU > 100 mL and
preoperative DO. Odds ratios (OR) with 95% conﬁdence intervals
(CI) were calculated as appropriate. All statistical analyses were
performed by using SPSS for Windows (version 17; SPSS Inc., Chi-
cago, IL, USA). Probability values < 0.05 were regarded as statisti-
cally signiﬁcant.Results
We identiﬁed 183 patients from the medical records who met
the criteria for inclusion. Nine patients were lost follow-up within
12 months. The mean follow-up period was 26 months (range,
12e50 months). Of the 174 women who underwent TVM pro-
cedures, 49 (28.2%) had preoperative UUI and 23 (13.2%) had
postoperative UUI, including 10 (5.7%) with persistent UUI and 13
(7.5%) exhibiting de novo UUI. At the 1-year follow-up, all patients
with UUI were treated with anticholinergics and improved their
lower urinary tract symptoms. The mean age, prevalence of pre-
operative DO, and maximal cystometric capacity (MCC) < 300 mL
were signiﬁcantly higher in patients with UUI than without it
(Table 1). Among the eight patients (4.6%) who had vaginal mesh
erosions, six underwent an excision of the exposed mesh, and the
other two were treated with topical estrogen cream. Nine of 174
(5.2%) patients who had undergone TVM had recurrent Stage 2 POP
(7 cystocele and 2 rectocele) at the 12-month follow-up, but all
required no prolapse repair.
Forty-nine patients with POP and preoperative UUI were treated
surgically with one or more transvaginal procedures (Table 2). The
POP-Q analyses of the 49 patients showed no prolapse greater than
Stage 2 after surgery. Of the 49 patients with preoperative UUI, 10
(20.4%) had persistent UUI and 19 (38.8%) developed de novo SUI
Table 2
Surgical procedures of women with pelvic organ prolapse.
UUI þ No UUI UUI No UUI
(Total n ¼ 174) (n ¼ 49) (n ¼ 125)
Anterior vaginal wall mesh 113 (64.9) 30 (61.2) 83 (66.4)
Perigee (n ¼ 74)
Anterior Prolift (n ¼ 39)
Anterior and posterior vaginal wall mesh 61 (35.1) 19 (38.8) 42 (33.6)
Perigee þ Apogee (n ¼ 40)
Anterior þ Posterior Prolift (n ¼ 21)
Concomitant procedures
Vaginal hysterectomy 149 (85.6) 42 (85.7) 107 (85.6)
Posterior colporrhaphy 22 (12.6) 5 (11.0) 17 (13.6)
Data are presented as n (%).
UUI ¼ urgency urinary incontinence.
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incontinence.
Prevalence of preoperative BOO, preoperative MCC< 300 mL,
preoperative severe bladder trabeculation, and duration of POP
symptoms > 60 months were signiﬁcantly higher in patients with
persistent UUI than without it (Table 3). Multivariable logistic
regression demonstrated that preoperative MCC< 300 mL
(OR ¼ 10.8, p ¼ 0.022), preoperative severe bladder trabeculation
(OR¼ 19.6, p¼ 0.008), and duration of POP symptoms > 60 months
(OR ¼ 9.077, p ¼ 0.040) were associated with persistent UUI after
POP repair. There was no signiﬁcant difference in the prevalence of
risk factors between patients with and without de novo SUI after
surgery. Nineteen patients had symptoms of SUI, but only seven
had objectively conﬁrmed SUI and were successfully treated by
transobturator tape procedures at the 1-year follow-up.
Discussion
The prevalence of UUI inwomenwith severe POP was 28.2% and
the incidence of de novo UUI was 7.5% after prolapse repair, a ﬁgure
lower than previously reported [15]. Lensen et al [15] reported a de
novo UUI occurrence of 21% for women undergoing POP surgery
without concomitant anti-incontinence procedures. While patients
with UUI were an average of 4 years older than the patients without
it, we could not attribute UUI to be principally generated by theTable 3
Characteristics of women with and without postoperative urgency urinary incon-






Age (y) 68.5 ± 11.1 68.0 ± 10.1 0.88
BMI (kg/m2) 23.6 ± 2.2 25.3 ± 3.0 0.09
Parity 4.7 ± 1.6 4.6 ± 1.6 0.91
Duration of POP (mo) 56.8 ± 40.2 40.2 ± 42.8 0.27
DM 1 (10) 5 (12.8) 1.0
Duration of POP > 60 mo 7 (70) 12 (30.8) 0.033
ICS Stage 4 7 (70) 15 (38.5) 0.090
Preop voiding difﬁculty 7 (70) 18 (46.2) 0.29
Protruding vaginal mass 9 (90) 36 (92.3) 0.912
Bearing down sensation 8 (80) 32 (82.1) 0.434
Severe preop trabeculation 7 (70) 8 (20.5) 0.005
Preop BOO 4 (40) 3 (7.7) 0.025
Preop MCC < 300 mL 7 (70) 9 (23.1) 0.008
Preop RU > 100 mL 6 (60) 10 (25.6) 0.06
Preop DO 1 (10) 6 (15.4) 1.0
Data are presented as n (%).
BMI¼ body mass index; BOO ¼ bladder outlet obstruction; DM¼ diabetes mellitus;
DO¼ detrusor overactivity; ICS¼ International Continence Society; MCC¼maximal
cystometric capacity; POP ¼ pelvic organ prolapse; Preop ¼ preoperative;
RU ¼ residual urine.aging process; more than 80% of patients with similar stages of POP
were postmenopausal, and the vast majority were aged 65 years.
However, in women older than 65 years, both UUI and mixed uri-
nary incontinence were reported the most prevalent types of uri-
nary incontinence [16]. In these elderly women, increased bladder
sensation, decreased bladder capacity, and increased DO were
observed [16]. Urodynamic results in the current study showed
lower MCC and a higher prevalence of DO in women with preop-
erative UUI compared to those without it. Severe POP can cause
urethral kinking or external compression and thus BOO, which
promotes uninhibited detrusor contractions [17]. We found that
8.6% (15/174) of patients were diagnosed with DO. Previous authors
have reported that DO was a strong predictor of postoperative
persistence of urgency and UUI [18], but we did not observe any
correlation between DO and UUI.
POP can cause BOO, and this is often regarded as an important
mechanism for the development of UUI and other OAB symptoms
in POP patients [19]. Several previous studies have reported that
OAB symptoms improved after successful treatment of POP
[16,19e21]. Basu and Duckett [21] found that 53% (22/40) of pa-
tients having nonmesh procedures for prolapse surgery experi-
enced resolution of their OAB, and maximal ﬂow rate was a
signiﬁcant predictor of improved OAB symptoms after surgery.
Long et al [17] observed that women with POP experienced
improvement of their OAB symptoms after TVM repair and pre-
operative DO was the only signiﬁcant predictor of symptom relief.
They suggested postoperative OAB improvement after mesh repair
is related to the release of urethral obstruction. In our study, UUI
related to POP was totally obviated in 80% (39/49) of women with
severe prolapse after surgical correction. Nguyen and Bhatia [2]
reported 63% (24/38) resolution of UUI among 38 patients with
severe POP after prolapse correction surgery. Foster et al [10] re-
ported a signiﬁcant reduction of urgency and frequency symptoms
6 months after vaginal reconstructive and obliterating surgeries
and a similar signiﬁcant reduction in urgency and UUI at 1 year
after surgery.
Our data demonstrated that the prevalence of BOO was 12.6%
(n ¼ 22) among the 174 patients studied, and patients with
persistent UUI had a greater prevalence of BOO than those without
it did. We also found that women with more severe bladder tra-
beculation had signiﬁcantly greater UUI than did patients with no
to moderate trabeculation. BOO caused by severe POP results in
hypertrophy of the bladder muscle and development of trabecu-
lation [3,22]. Previous investigators reported that bladder trabe-
culation on voiding cystography was strongly associated with UUI
in a population of community dwelling elderly women [23]. Gowda
et al [24] observed that bladder trabeculation was associated with
ICS Stage 4 anterior vaginal wall prolapse as well as with DO and
UUI. Our results showed that longer durations of POP symptoms
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MCC< 300 mL resulted in persistent UUI symptoms after prolapse
repair. However, whether trabeculation is related to bladder
dysfunction with irreversible changes at the cellular level or a sign
of reversible compensation due to urethral obstruction is not clear
[25].
Our results showed TVM procedure is effective in treating pa-
tients with severe POP, with 12-month recurrent rate at around 5%,
compatible with what prior literature had indicated [26]. Long et al
[26] reported Perigee/Apogee and Prolift system had an overall
success rate of 96% for the treatment of POP. In this study, the
incidence of de novo SUI following TVM repair of POP in women
with UUI was 32.7% (16/49), which was compatible with previous
studies [27]. A recent study reported a high incidence of de novo SUI
of up to 43% (74/172) at 12 months after vaginal prolapse repair
where no mid-urethral sling procedure was performed in com-
parison with an incidence of 27.3% (45/165) in patients undergoing
concomitant mid-urethral sling procedures [28]. However,
routinely performing a prophylactic anti-incontinence procedure
during prolapse repair regardless of the presence or absence of
demonstrable incontinence is unjustiﬁed because the prophylactic
procedure exposes many women to unnecessary morbidity. We did
not ﬁnd a meaningful predictor for the occurrence of de novo SUI in
women with preoperative UUI after TVM repair.
Limitations of the present study include its retrospective study
design and small case number. The strengths of this analysis
include that all patients underwent a TVM repair, although some
women needed more than one compartment repaired, cystoscopy
performed by a single investigator, urodynamic testing performed
at a single laboratory, and the assessment of patient-reported
urologic symptoms with a structured questionnaire. Furthermore,
this study produced results that could be potentially beneﬁcial in
providing preoperative patient counseling. The assessment and
clariﬁcation of preoperative patient expectations, including dis-
cussing the possibility of persistent symptoms postoperatively is
critical in achieving adequate patient satisfaction.
In conclusion, following POP repair, 20% of women with pre-
operative UUI had persistent postoperative UUI. For women with
identiﬁed preoperative risk factors of MCC< 300 mL, severe
bladder trabeculation, and POP symptoms > 60 months, preoper-
atively counseling them on probable persistent UUI symptoms
postoperatively and development of de novo SUI after surgery are
advisable.Conﬂicts of interest
The authors have no conﬂicts of interest relevant to this article.References
[1] Groutz A, Blaivas JG, Chaikin DC. Bladder outlet obstruction in women: deﬁ-
nition and characteristics. Neurourol Urodyn 2000;19:213e20.
[2] Nguyen JK, Bhatia NN. Resolution of motor urge incontinence after surgical
repair of pelvic organ prolapse. J Urol 2001;66:2263e6.
[3] Liang CC, Chang YL, Lin YH, Chang SD. Signiﬁcance of bladder trabeculation in
postmenopausal women with severe pelvic organ prolapse: clinical and
urodynamic assessments. Menopause 2013;20:813e7.
[4] Coates KW, Harris RL, Cundiff GW, Bump RC. Uroﬂowmetry in women with
urinary incontinence and pelvic organ prolapse. Br J Urol 1997;80:217e21.[5] Ellerkmann RM, Cundiff WC, Melick CF, Nihira MA, Lefﬂer K, Bent AE. Corre-
lation of symptoms with location and severity of pelvic organ prolapse. Am J
Obstet Gynecol 2001;185:1332e8.
[6] Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, et al. An
International Urogynecological Association (IUGA)/International Continence
Society (ICS) joint report on the terminology for female pelvic ﬂoor
dysfunction. Int Urogynecol J 2010;21:5e26.
[7] Abrams P, Kelleher CJ, Kerr LA, Rogers RG. Overactive bladder signiﬁcantly
affects quality of life. Am J Manag Care 2000;6(11 Suppl.):S580e90.
[8] Stewart WF, Van Rooyen JB, Cundiff GW, Abrams P, Herzog AR, Corey R, et al.
Prevalence and burden of overactive bladder in the United States. World J Urol
2003;20:327e36.
[9] Liang CC, Tseng LH, Chang SD, Chang YL, Lo TS. Resolution of elevated postvoid
residual volumes after correction of severe pelvic organ prolapse. Int Urogy-
necol J 2008;19:1261e6.
[10] Foster RT, Matthew D, Barber MD, Walters MD, Weidner AC, Amundsen CL.
A prospective assessment of overactive bladder symptoms in a cohort of
elderly women who underwent transvaginal surgery for advanced pelvic
organ prolapse. Am J Obstet Gynecol 2007;197:82.e1e4.
[11] Bump RC, Mattiasson A, Bo K, Brubaker LP, DeLancey JO, Klarskov P, et al. The
standardization of terminology of female pelvic organ prolapse and pelvic
ﬂoor dysfunction. Am J Obstet Gynecol 1996;175:10e7.
[12] Liang CC, Chang YL, Chang SD, Lo TS, Soong YK. Pessary test to predict post-
operative urinary incontinence in women undergoing hysterectomy for pro-
lapse. Obstet Gynecol 2004;104:795e800.
[13] Liang CC, Tseng LH, Horng SG, Lin IW, Chang SD. Correlation of pelvic organ
prolapse quantiﬁcation system scores with obstetric parameters and lower
urinary tract symptoms in primiparae postpartum. Int Urogynecol J 2007;18:
537e41.
[14] Abrams P, Cardozo L, Fall M, Grifﬁths D, Rosier P, Ulmsten U, et al. The
standardization of terminology of lower urinary tract function: report from
the Standardization Sub-committee of the International Continence Society.
Neurourol Urodyn 2002;21:167e78.
[15] Lensen EJ, Withagen MI, Kluivers KB, Milani AL, Vierhout ME. Urinary in-
continence after surgery for pelvic organ prolapse. Neurourol Urodyn
2013;32:455e9.
[16] Vecchioli-Scaldazza C, Morosetti C. Effect of aging on urinary incontinence in
woman. Arch Ital Urol Androl 2010;82:167e71.
[17] Long CY, Hsu CS, Wu MP, Liu CM, Chiang PH, Juan YS, et al. Predictors of
improved overactive bladder symptoms after transvaginal mesh repair for the
treatment of pelvic organ prolapse. Int Urogynecol J 2011;22:535e42.
[18] Araki I, Haneda Y, Mikami Y, Takeda M. Incontinence and detrusor dysfunc-
tion associated with pelvic organ prolapse: clinical value of preoperative
urodynamic evaluation. Int Urogynecol J 2009;20:1301e6.
[19] de Boer TA, Salvatore S, Cardozo L, Chapple C, Kelleher C, van Kerrebroeck P,
et al. Pelvic organ prolapse and overactive bladder. Neurourol Urodyn
2010;29:30e9.
[20] de Boer TA, Kluivers KB, Withagen MIJ, Milani AL, Vierhout ME. Predictive
factors for overactive bladder symptoms after pelvic organ prolapse surgery.
Int Urogynecol J 2010;21:1143e9.
[21] Basu M, Duckett J. Effect of prolapse repair on voiding and the relationship to
overactive bladder and detrusor overactivity. Int Urogynecol J 2009;20:
499e504.
[22] Bai SW, Park SH, Chung DJ, Park JH, Shin JS, Kim SK, et al. The signiﬁcance of
bladder trabeculation in the female lower urinary system: an objective
evaluation by urodynamic studies. Yonsei Med J 2005;46:673e8.
[23] Fielding JR, Lee JH, Dubeau CE, Zou KH, Resnick NM. Voiding cystourethrog-
raphy ﬁndings in elderly women with urge incontinence. J Urol 2000;163:
1216e8.
[24] Gowda M, Danford JM, Hu Y, Slaughter JC, Zimmerman CW, Ward RM. Clinical
ﬁndings associated with bladder trabeculations in women. Int Urogynecol J
2013;24:1167e71.
[25] el Din K, de Wildt M, Rosier P, Wijkstra H, Debruyne F, de la Rosette J. The
correlation between urodynamic and cystoscopic ﬁndings in elderly men with
voiding complaints. J Urol 1996;155:1018e22.
[26] Long CY, Hsu CS, Jang MY, Liu CM, Chiang PH, Tsai EM. Comparison of clinical
outcome and urodynamic ﬁndings using “Perigee and/or Apogee” versus
“Prolift anterior and/or posterior” system devices for the treatment of pelvic
organ prolapse. Int Urogynecol J 2011;22:233e9.
[27] Haﬁdh BA, Chou Q, Khalil MM, Al-Mandeel H. De novo stress urinary incon-
tinence after vaginal repair for pelvic organ prolapse: one-year follow-up. Eur
J Obstet Gynecol Reprod Biol 2013;168:227e30.
[28] Wei J, Nygaard I, Richter H, Nager CW, Barber MD, Kenton K, et al.
A midurethral sling to reduce incontinence after vaginal prolapse repair.
N Engl J Med 2012;366:2358e67.
